Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Leuk Lymphoma. 2023 Sep 14;64(13):2195–2201. doi: 10.1080/10428194.2023.2255706

Table 1.

Patient characteristics

No. (%)

Median age (years) 67

Sex
 Female 8 (62)

Smoking status
 Never 6 (46)
 Current 0 (0)
 Past (≤10 years) 1 (8)
 Distant past (>10 years) 6 (46)

COPD 0 (0)

Autoimmune/connective tissue disease 0 (0)

History of cancer 5 (38)

Cancer during follow up 1 (8)

Symptoms prior to RT
 Dyspnea 4 (31)
 Cough 2 (15)
 B symptoms 0 (0)

KPS
 ≤70 0 (0)

Bilateral lung involvement 4 (31)

No. of lesions
 1 8 (62)
 ≥2 5 (38)

Median size, cm 3.6 (0.8 – 8.2)

Size category, cm,§
 ≤1 2 (13)
 >1 to ≤2 2 (13)
 >2 11 (73)

Nodal disease in chest 1 (8)

Anemia (Hb <11.2 g/dL) 1 (8)

Neutropenia (<1.5 × 103/μL) 0 (0)

Thrombocytopenia (<150 × 103/μL) 1 (8)

LDH > ULN* 1 (13)

Myelodysplastic syndrome

Of 15 treated lesions

§

Largest diameter

*

Pre-RT LDH prior to radiotherapy available for 8 patients